Cyclosphosphamide
Showing 1 - 25 of 29
Recurrent Nasopharyngeal Undifferentiated Carcinoma, Stage IV Nasopharyngeal Undifferentiated Carcinoma Trial (Cyclophosphamide)
Completed
- Recurrent Nasopharyngeal Undifferentiated Carcinoma
- Stage IV Nasopharyngeal Undifferentiated Carcinoma
- (no location specified)
Sep 29, 2019
Haplo-identical Transplants in Fanconi Disease
Not yet recruiting
- Fanconi Syndrome
- Blood sampling
- (no location specified)
Jun 6, 2023
Ewing's Sarcoma Trial in Italy (Standard treatment (as per protocol ISG SSG III), Intensified chemo)
Active, not recruiting
- Ewing's Sarcoma
- Standard treatment (as per protocol ISG SSG III)
- Intensified chemotherapy
-
Aviano, Pordenone, Italy
- +13 more
Oct 29, 2021
Non-GCB/ABC DLBCL Trial in Suzhou (Zanubrutinib, Rituximab, Cyclophosphamide)
Recruiting
- Non-GCB/ABC Diffuse Large B-Cell Lymphoma
- Zanubrutinib
- +5 more
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Apr 12, 2021
Biosimilars of Rituximab in ANCA-associated Vasculitis Compared
Recruiting
- ANCA-associated Vasculitis
- +2 more
-
Calgary, Alberta, Canada
- +8 more
Jan 27, 2023
Lymphoma Trial in Minneapolis (drug, procedure, radiation, biological)
Completed
- Lymphoma
- carmustine
- +6 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Jul 10, 2020
Interstitial Pneumonitis, Polymyositis, Dermatomyositis Trial in Japan (Tacrolimus)
Completed
- Interstitial Pneumonitis
- +2 more
-
Sapporo, Hokkaido, Japan
- +10 more
Mar 10, 2020
Biopsy-proven IgA Nephropathy Trial in Seoul (Immunosuppressive treatment, intensive supportive care)
Not yet recruiting
- Biopsy-proven IgA Nephropathy
- Immunosuppressive treatment
- intensive supportive care
-
Seoul, Korea, Republic ofSeverance Hospital
Feb 7, 2019
EBMT ADWP Prospective Non-interventional Study: Post-AHSCT
Recruiting
- Autoimmune Diseases
- Autologous HSCT
-
Paris, FranceBadoglio Manuela- EBMT Paris Office
Aug 29, 2019
Leukemia, Myeloid, Chronic, Lymphomas, Multiple Myeloma Trial in Minneapolis (Donor Lymphocyte Infusion, Induction Chemotherapy)
Terminated
- Leukemia, Myeloid, Chronic
- +6 more
- Donor Lymphocyte Infusion
- Induction Chemotherapy
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Jul 10, 2019
Chronic Lymphocytic Leukemia, GVHD, Hematologic Tumor Trial run by the NHLBI (Isolex 300i plus MoAbs)
Completed
- Chronic Lymphocytic Leukemia
- +4 more
- Isolex 300i plus MoAbs
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 25, 2018
Breast Cancer Trial in Singapore (Neoadjuvant Docetaxel and Cyclophosphamide)
Completed
- Breast Cancer
- Neoadjuvant Docetaxel and Cyclophosphamide
-
Singapore, SingaporeNational Cancer Centre Singapore
Sep 12, 2018
Multiple Myeloma Trial in United Kingdom (Induction (intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone (CRD)
Unknown status
- Multiple Myeloma
- Induction (intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone (CRD) regimen
- +8 more
-
United Kingdom, United Kingdom112 sites UK wide
Jun 7, 2018
Lymphoma, B-cell Lymphoma, Non Hodgkin Lymphoma Trial in Baltimore (drug, radiation, biological)
Terminated
- Lymphoma
- +3 more
- Fludarabine
- +6 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jul 26, 2018
Diffuse Large B-cell Lymphoma Trial in Lund (Valproate, Rituximab, Cyclophosphamide)
Completed
- Diffuse Large B-cell Lymphoma
- Valproate
- +5 more
-
Lund, SwedenSkåne University Hospital, Dept. of Oncology
Mar 9, 2018
Breast Cancer Trial in Minneapolis (drug, radiation, other, biological)
Terminated
- Breast Cancer
- Fludarabine
- +4 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Dec 3, 2017
Non-Hodgkin's Lymphoma, CNS Lymphoma Trial in Boston (Autologous stem cell transplant, High-dose chemo)
Completed
- Non-Hodgkin's Lymphoma
- CNS Lymphoma
- Autologous stem cell transplant
- High-dose chemotherapy
-
Boston, Massachusetts
- +1 more
Nov 27, 2017
Ovarian Cancer, Primary Peritoneal Cancer Trial in Philadelphia (DCVax-L and T Cells)
Withdrawn
- Ovarian Cancer
- Primary Peritoneal Cancer
- DCVax-L and T Cells
-
Philadelphia, PennsylvaniaUniversity of Pennsylania
Apr 28, 2017
Chronic Lymphocytic Leukemia Trial in Pittsburgh (Fludarabine, Cyclophosphamide, Rituximab)
Completed
- Chronic Lymphocytic Leukemia
- Fludarabine
- +2 more
-
Pittsburgh, PennsylvaniaHillman Cancer Center
Jan 5, 2016
Leukemia, Lymphoma, MDS Trial in Atlanta (busulfan, cyclophosphamide, fludarabine phosphate)
Completed
- Leukemia
- +2 more
- busulfan
- +6 more
-
Atlanta, GeorgiaBlood and Marrow Transplant Group of Georgia
Oct 28, 2013
Unrelated Stem Cell Transplantation for Hematopoietic Disorders
Completed
- CML
- +5 more
-
San Francisco, CaliforniaUniversity of California San Francisco
Aug 1, 2013
Acute Lymphoblastic Leukemia Trial in Salt Lake City (RAPAMYCIN)
Completed
- Acute Lymphoblastic Leukemia
-
Salt Lake City, UtahPrimary Children's Medical Center
Jul 23, 2013
Breast Cancer Trial in Houston (Taxotere, Adriamycin/cytoxan)
Completed
- Breast Cancer
-
Houston, TexasBaylor Breast Center
Jan 24, 2012